A Closer Look at 4 Analyst Recommendations For Expensify
Portfolio Pulse from Benzinga Insights
Expensify (NASDAQ:EXFY) received mixed analyst ratings with 3 indifferent and 1 somewhat bearish over the past three months. The average 12-month price target is now $2.75, down from $4.50, indicating a 38.89% decrease. Analysts from Piper Sandler and Morgan Stanley have adjusted their price targets and ratings, reflecting changes in market conditions and company performance. Expensify's financials show a revenue decline of -14.12% over 3 months, a net margin of -46.59%, an ROE of -17.45%, an ROA of -8.01%, and a debt-to-equity ratio of 0.69.
January 02, 2024 | 3:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Expensify's mixed analyst ratings and lowered price targets suggest cautious investor sentiment. Financial challenges such as revenue decline and low net margin may pressure the stock short term.
The reduction in the average price target by analysts, combined with the company's recent financial performance challenges, such as a significant revenue decline and a low net margin, are likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100